A Multicenter Trial of the Efficacy and Safety of Bonjesta® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents
Latest Information Update: 19 Sep 2023
At a glance
- Drugs Doxylamine/pyridoxine (Primary)
- Indications Nausea and vomiting
- Focus Registrational; Therapeutic Use
- Sponsors Duchesnay Inc
- 08 Sep 2023 Planned End Date changed from 1 Dec 2025 to 1 Dec 2027.
- 08 Sep 2023 Planned primary completion date changed from 1 Dec 2025 to 1 Dec 2027.
- 08 Sep 2023 Status changed from not yet recruiting to recruiting.